Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

309 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Relationship between lipid levels and clinical outcomes in the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Trial: to what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels?
Simes RJ, Marschner IC, Hunt D, Colquhoun D, Sullivan D, Stewart RA, Hague W, Keech A, Thompson P, White H, Shaw J, Tonkin A; LIPID Study Investigators. Simes RJ, et al. Among authors: stewart ra. Circulation. 2002 Mar 12;105(10):1162-9. doi: 10.1161/hc1002.105136. Circulation. 2002. PMID: 11889008
Depression and cardiovascular morbidity and mortality: cause or consequence?
Stewart RA, North FM, West TM, Sharples KJ, Simes RJ, Colquhoun DM, White HD, Tonkin AM; Long-Term Intervention With Pravastatin in Ischaemic Disease (LIPID) Study Investigators. Stewart RA, et al. Eur Heart J. 2003 Nov;24(22):2027-37. doi: 10.1016/j.ehj.2003.08.017. Eur Heart J. 2003. PMID: 14613739 Clinical Trial.
White blood cell count predicts reduction in coronary heart disease mortality with pravastatin.
Stewart RA, White HD, Kirby AC, Heritier SR, Simes RJ, Nestel PJ, West MJ, Colquhoun DM, Tonkin AM; Long-Term Intervention With Pravastatin in Ischemic Disease (LIPID) Study Investigators. Stewart RA, et al. Circulation. 2005 Apr 12;111(14):1756-62. doi: 10.1161/01.CIR.0000160924.73417.26. Epub 2005 Apr 4. Circulation. 2005. PMID: 15809366 Clinical Trial.
Patients with prolonged ischemic chest pain and presumed-new left bundle branch block have heterogeneous outcomes depending on the presence of ST-segment changes.
Wong CK, French JK, Aylward PE, Stewart RA, Gao W, Armstrong PW, Van De Werf FJ, Simes RJ, Raffel OC, Granger CB, Califf RM, White HD; HERO-2 Trial Investigators. Wong CK, et al. Among authors: stewart ra. J Am Coll Cardiol. 2005 Jul 5;46(1):29-38. doi: 10.1016/j.jacc.2005.02.084. J Am Coll Cardiol. 2005. PMID: 15992631 Free article.
Frequency of recurrent ST-elevation myocardial infarction after fibrinolytic therapy in a different territory as a manifestation of multiple unstable coronary arterial plaques.
Edmond JJ, French JK, Stewart RA, Aylward PA, De Pasquale CG, Williams BF, O'Connell RL, Simes RJ, White HD; HERO-2 Investigators. Edmond JJ, et al. Among authors: stewart ra. Am J Cardiol. 2006 Apr 1;97(7):947-51. doi: 10.1016/j.amjcard.2005.10.031. Epub 2006 Feb 13. Am J Cardiol. 2006. PMID: 16563892
Risk stratification of patients with acute anterior myocardial infarction and right bundle-branch block: importance of QRS duration and early ST-segment resolution after fibrinolytic therapy.
Wong CK, Gao W, Stewart RA, van Pelt N, French JK, Aylward PE, White HD; Hirulog Early Reperfusion Occlusion (HERO-2) Investigators. Wong CK, et al. Among authors: stewart ra. Circulation. 2006 Aug 22;114(8):783-9. doi: 10.1161/CIRCULATIONAHA.106.639039. Epub 2006 Aug 14. Circulation. 2006. PMID: 16908761
309 results